These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 27792291)

  • 21. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
    Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
    Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic Impact of Tumor Location of Colorectal Cancer in Patients with Resected Liver Metastasis].
    Ogura T; Muta Y; Ito T; Chika N; Hatano S; Amano K; Ishiguro T; Fukuchi M; Kumagai Y; Ishibashi K; Mochiki E; Ishida H
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1461-1463. PubMed ID: 29394668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
    Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
    Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the site of primary colorectal cancer influence the outcome after resection of isolated liver metastases?
    Makowiec F; Menzel M; Bronsert P; Holzner PA; Klock A; Lang SA; Fichtner-Feigl S; Neeff HP
    Dig Liver Dis; 2018 Oct; 50(10):1088-1092. PubMed ID: 30055964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
    Margonis GA; Buettner S; Andreatos N; Wagner D; Sasaki K; Galjart B; Kamphues C; Pawlik TM; Poultsides G; Kaczirek K; Lønning PE; Verhoef C; Kreis ME; Wolfgang CL; Weiss MJ
    J Surg Oncol; 2018 Dec; 118(7):1074-1080. PubMed ID: 30261094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overall survival by pattern of recurrence following curative intent surgery for colorectal liver metastasis.
    Kulaylat AN; Schubart JR; Stokes AL; Bhayani NH; Wong J; Kimchi ET; O'Carroll KF; Kaifi JT; Gusani NJ
    J Surg Oncol; 2014 Dec; 110(8):1011-5. PubMed ID: 25146500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
    Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
    J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity.
    Viganò L; Ferrero A; Lo Tesoriere R; Capussotti L
    Ann Surg Oncol; 2008 Sep; 15(9):2458-64. PubMed ID: 18463927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
    Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
    Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resection of liver metastases from colorectal mucinous adenocarcinoma: is this a different disease? Results of a case-control study.
    Viganò L; Russolillo N; Ferrero A; De Rosa G; Ferreri E; Forchino F; Sperti E; Capussotti L
    Ann Surg; 2014 Nov; 260(5):878-84; discussion 884-5. PubMed ID: 25379857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases.
    Shimomura M; Hinoi T; Kuroda S; Adachi T; Kawaguchi Y; Sasada T; Takakura Y; Egi H; Okajima M; Tashiro H; Nishizaka T; Ohdan H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S527-36. PubMed ID: 23748663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcopenia and primary tumor location influence patients outcome after liver resection for colorectal liver metastases.
    Bajrić T; Kornprat P; Faschinger F; Werkgartner G; Mischinger HJ; Wagner D
    Eur J Surg Oncol; 2022 Mar; 48(3):615-620. PubMed ID: 34620509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
    Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI
    Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphatic Invasion is an Independent Adverse Prognostic Factor in Patients with Colorectal Liver Metastasis.
    de Ridder JA; Knijn N; Wiering B; de Wilt JH; Nagtegaal ID
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S638-45. PubMed ID: 25986865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is primary sidedness a prognostic factor in patients with resected colon cancer liver metastases (CLM)?
    Marques MC; C Ribeiro HS; Costa WL; de Jesus VHF; de Macedo MP; Diniz AL; Godoy AL; Farias IC; Aguiar S; Riechelmann RSP; S Begnami MDF; Coimbra FJF
    J Surg Oncol; 2018 Apr; 117(5):858-863. PubMed ID: 29611198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Right and extended-right hepatectomies for unilobar colorectal metastases: impact of portal vein embolization on long-term outcome and liver recurrence.
    Ardito F; Vellone M; Barbaro B; Grande G; Clemente G; Giovannini I; Federico B; Bonomo L; Nuzzo G; Giuliante F
    Surgery; 2013 Jun; 153(6):801-10. PubMed ID: 23701876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of the primary tumour location in patients undergoing surgery for colorectal liver metastases.
    Dupré A; Malik HZ; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ
    Eur J Surg Oncol; 2018 Jan; 44(1):80-86. PubMed ID: 29183640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery.
    Lee HS; Kim HO; Hong YS; Kim TW; Kim JC; Yu CS; Kim JS
    J Nucl Med; 2014 Apr; 55(4):582-9. PubMed ID: 24549284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.